2008 Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and LYN Kinase... Evaluation of Trends in the Cost of Initial Cancer Treatment... Invasive Breast Cancer With Raloxifene: Women at Increased Coronary Risk... Estrogen-Dependent Signaling in a Subclass of Aggressive Prostate Cancer... Fluorouracil, Epirubicin, and Cyclophosphamide Alone or With Paclitaxel... Residual Treatment Disparities After Oncology Referral for Rectal Cancer... 18F-Fluorodeoxyglucose Positron Emission Tomography and Cervical Node Mets... Treating Metastatic Solid Tumors With Bortezomib and Tumor Necrosis Factor... Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy... Vinorelbine-Capecitabine VersusDocetaxel-Doxorubicin-Cyclophosphamide... Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer... Disparities and Trends in Sentinel Lymph Node Biopsy ... Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors... Adjuvant Chemotherapy in Completely Resected Gastric Cancer... Cyclooxygenase-2 Expression in Atypical Hyperplasia and Breast Cancer... Modulated Radiation Therapy Dose Prescription, Recording, and Delivery... Effect of Interleukin-8 Gene on Ovarian Cancer Cell Growth... Patients With Human Papillomavirus?Positive Head Carcinoma ... Cause of Death From a Trial of Adjuvant Endocrine Therapy for Breast Cancer... Endogenous Sex Hormones and Prostate Cancer... Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia... The Association Between Statins and Cancer Incidence ... Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline ... Effect of Systemic Adjuvant Treatment on Risk for Contralateral Breast CA... HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer... 2007 Extended Adjuvant Therapy With Anastrozole ... Cancer Incidence in Blood Transfusion Recipients... Projecting Individualized Absolute Invasive Breast Cancer Risk ... 18Fluorodeoxyglucose Positron Emission Tomography in Lung Cancer... Molecular Basis for Estrogen Receptor Deficiency in BRCA1-Linked Breast CA... Predicting Risk of Breast Cancer in Postmenopausal Women ... Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology ... Atopy and Risk of Brain Tumors: A Meta-analysis... ADT for Localized Prostate Cancer and the Risk of Cardiovascular Mortality... Fruits, Vegetables, and Colon Cancer Risk in a Pooled Analysis... Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests... Cancer Mortality in the United States by Education Level and Race... Finasteride and High-Grade Prostate Cancer... Interval Cancers in Prostate Cancer Screening... Comparative Mortality for Second Cancers Testicular Cancer Survivors... Arterial Thromboembolic Events in Patients With Metastatic Carcinoma... Breast Cancer Incidence, 1980?2006: HT, Mammography, & Receptor Status... Surgical Learning Curve for Cancer Control After Radical Prostatectomy... More Clinical Cancer Treatments Judged by PFS Than Overall Survival... Inconsistency of HER2 Test Raises Questions... Biomarker-adaptive Threshhold Design... Endpoints in Adjuvant Treatment Trials... Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers... Cisplatin- Versus Carboplatin-Based Chemotherapy... Mass Spectrometry to Classify NSCLC Patients for Clinical Outcome... Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma... Oral Sodium Clodronate for Nonmetastatic Prostate Cancer... Immunochemotherapy With Rituximab and Overall Survival ... Tamoxifen for the Prevention of Breast Cancer... Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients... Potential Drug Interactions and Duplicate Prescriptions In Cancer Patients... Polychemotherapy for Early Breast Cancer... Ovarian Ablation or Suppression in Premenopausal Early Breast Cancer... | 
